A cohort study of patients with atrial fibrillation (AF) and low risk for stroke has found that the use of early rhythm control therapy was associated with a lower risk of cardiovascular death, ischemic stroke, hospitalization for heart failure, or myocardial infarction compared to rate control therapy. The findings are published in Annals of Internal Medicine.